PRFXNasdaqPharmaceutical PreparationsFiscal year ends December 31
PRF Technologies Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$0.71−0.07 (-8.88%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns PRF Technologies's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| YA II PN, Ltd. | 66,625 | 9.99% | 13G (passive) | May 7, 2026 |
| Medica III Management Co. | 346,478 | 19.85% | 13G (passive) amendment | Dec 31, 2023 |
| YA Global Investments II (U.S.), LP | 333,105 | 9.99% | 13G (passive) amendment | Jun 18, 2026 |
| S.H.N. Financial Investments Ltd. | 200,000 | 5.72% | 13D (active) | Sep 24, 2026 |
| XT Hi-Tech Investments (1992) Ltd | 106,588 | 5.20% | 13G (passive) amendment | Dec 31, 2023 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Efraim Cohen-Arazi | Interim CEO, Director | – | – | Mar 18, 2026 |
| Ehud Geller | Exec Chairman of the Board, Director | – | – | Mar 18, 2026 |
| Eyal Broder | Chief Financial Officer | – | – | Mar 18, 2026 |
| Sigal Aviel | Chief Operating Officer | – | – | Mar 18, 2026 |
| Asaf Shavit | Director | – | – | Mar 18, 2026 |
| Ellen S. Baron | Director | – | – | Mar 18, 2026 |
| Augustine Lawlor | Director | – | – | Mar 18, 2026 |